Control of hyperglycaemia in paediatric intensive care (CHiP): Study protocol

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Macrae, Duncan ^a   Pappachan, John ^b   Grieve, Richard ^c   Parslow, Roger ^d   Nadel, Simon ^e   Schindler, Margrid ^f   Baines, Paul ^g   Fortune, Peter Marc ^h   Slavik, Zdenek ^a   Goldman, Allan ⁱ   Truesdale, Ann ^c   Betts, Helen ^a   Allen, Elizabeth ^c   Snowdon, Claire ^c   Percy, Deborah ^c   Broadhead, Michael ⁱ   Quick, Tara ^c   Peters, Mark ⁱ   Morris, Kevin ^j   Tasker, Robert ^k   Elbourne, Diana ^c   more..

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^g ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^h ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

ⁱ GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^j BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; INSULIN; MILRINONE; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; ATTENTION; BLOOD GLUCOSE MONITORING; CHILD; CHILD BEHAVIOR; CHILDHOOD INJURY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DRUG DOSE TITRATION; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH STATUS; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; MAJOR SURGERY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TRAUMATIC BRAIN INJURY; UNITED KINGDOM; VENTILATOR; VITAL SIGN; ADULT; AGE; BLOOD; COMPARATIVE STUDY; DRUG MONITORING; INJURY; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MULTICENTER STUDY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; STATISTICS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; CRITICAL ILLNESS; DRUG MONITORING; ENGLAND; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; INSULIN; INTENSIVE CARE UNITS, PEDIATRIC; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VENTILATOR WEANING; WOUNDS AND INJURIES;

EID: 77649086894     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-5     Document Type: Article

References (61)

1. Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN clinical issues 2006, 17:50.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-8. 10.1016/S0140-6736(99)08415-9, 10711923.
3. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-32. 10.1161/hs1001.096194, 11588337.
4. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000, 46:335-42. 10.1097/00006123-200002000-00015, 10690722.
5. Paret G, Tirosh R, Lotan D, Stein M, Ben-Abraham R, Vardi A, Harel R, Barzilay Z. Early prediction of neurological outcome after falls in children: metabolic and clinical markers. J Accid Emerg Med 1999, 16:186-8. 1343331, 10353044.
6. Chiaretti A, De Benedictis R, Langer A, Di Rocco C, Bizzarri C, Iannelli A, Polidori G. Prognostic implications of hyperglycaemia in paediatric head injury. Childs Nerv Syst 1998, 14:455-9. 10.1007/s003810050259, 9808254.
7. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003, 55:33-8. 10.1097/01.TA.0000074434.39928.72, 12855878.
8. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, Jensen G, Schnohr P. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989, 2:14-9.
9. Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R. Pulmonary complications in diabetes mellitus: the role of glycemic control. Curr Drug Targets Inflamm Allergy 2004, 3:455-8. 10.2174/1568010042634488, 15584894.
10. Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R. Effects of hyperglycaemia and hyperinsulinaemia on proximal gastric motor and sensory function in humans. Clin Sci (Lond) 2000, 99:37-46. 10.1042/CS19990341, 10887056.
11. Russo A, Fraser R, Horowitz M. The effect of acute hyperglycaemia on small intestinal motility in normal subjects. Diabetologia 1996, 39:984-9. 10.1007/BF00403919, 8858222.
12. Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R. The effect of hyperglycaemia on cerebral potentials evoked by rapid rectal distension in healthy humans. Eur J Clin Invest 1999, 29:512-8. 10.1046/j.1365-2362.1999.00487.x, 10354213.
13. Russo A, Sun WM, Sattawatthamrong Y, Fraser R, Horowitz M, Andrews JM, Read NW. Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects. Gut 1997, 41:494-9. 1891535, 9391248.
14. Rayner CK, Smout AJ, Sun WM, Russo A, Semmler J, Sattawatthamrong Y, Tellis N, Horowitz M. Effects of hyperglycemia on cortical response to esophageal distension in normal subjects. Dig Dis Sci 1999, 44:279-85. 10.1023/A:1026642114971, 10063912.
15. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 2001, 70:395-404.
16. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10(Suppl 2):21-33.
17. Vriesendorp TM, Morélis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery: A retrospective study. Eur J Vasc Endovasc Surg 2004, 28:520-5. 10.1016/j.ejvs.2004.08.006, 15465374.
18. Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. NEJM 2001, 345:1359-68. 10.1056/NEJMoa011300, 11794168.
19. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997, 314:1512-5. 2126756, 9169397.
20. Malmberg K, Norhammar A, Wedel H, Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999, 99:2626-32.
21. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352-60. 10.1016/S0003-4975(99)00014-4, 10197653.
22. Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. NEMJ 2006, 354:449-61.
23. Angus DC, Abraham E. Intensive Insulin Therapy in Critical Illness. AJRCCM 2005, 172:1358-1359.
24. Institute for Healthcare Improvement. Surviving Sepsis Campaign. , http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis/SepsisSubtopicHomepage.htm
25. Angus DC, Abraham E. Intensive insulin therapy in critical illness. AJRCCM 2005, 172:1358-9.
26. Hoxworth JM, Xu K, Zhou Y, Lust WD, LaManna JC. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Res 1999, 821:467-79. 10.1016/S0006-8993(98)01332-8, 10064834.
27. Katsura K, Rodriguez de Turco EB, Siesjö BK, Bazan NG. Effects of hyperglycemia and hypercapnia on lipid metabolism during complete brain ischemia. Brain Res 2004, 1030:133-40. 10.1016/j.brainres.2004.10.007, 15567345.
28. Anderson RE, Tan WK, Martin HS, Meyer FB. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999, 30:160-70.
29. Li PA, Gisselsson L, Keuker J, Vogel J, Smith ML, Kuschinsky W, Siesjö BK. Hyperglycemia-exaggerated ischemic brain damage following 30 min of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res 1998, 804:36-44. 10.1016/S0006-8993(98)00651-9, 9729262.
30. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982, 32:1239-46.
31. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993, 24:111-6.
32. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002, 51:1076-82. 10.2337/diabetes.51.4.1076, 11916928.
33. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 2002, 51:1938-48. 10.2337/diabetes.51.4.1076, 12031984.
34. Ceriello A. Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 2005, 26:328-31. 10.1093/eurheartj/ehi049, 15618047.
35. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-72. 10.1161/01.CIR.0000034509.14906.AE, 12379575.
36. Oliver MF, Kurien VA, Greenwood TW. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968, 1:710-4. 10.1016/S0140-6736(68)92163-6, 4170959.
37. Ferrando AA. Anabolic hormones in critically ill patients. Curr Opin Clin Nutr Metab Care 1999, 2:171-5. 10.1097/00075197-199903000-00014, 10453350.
38. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999, 229:11-8. 10.1097/00000658-199901000-00002, 1191603, 9923795.
39. Das UN. Is insulin an antiinflammatory molecule?. Nutrition 2001, 17:409-13. 10.1016/S0899-9007(01)00518-4, 11377135.
40. Das UN. Insulin and inflammation: further evidence and discussion. Nutrition 2002, 18:526-7. 10.1016/S0899-9007(02)00767-0, 12044830.
41. Das UN. Is insulin an endogenous cardioprotector?. Crit Care 2002, 6:389-93. 10.1186/cc1535, 137317, 12398773.
42. Paediatric Intensive Care Audit Network National Report 2004-2006. , http://www.picanet.org.uk/Documents/General/Annual_Report_2007/PICANet%20National%20Report%202004%20-%202006.htm
43. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004, 5:329-36. 10.1097/01.PCC.0000128607.68261.7C, 15215001.
44. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 2005, 6:470-2. 10.1097/01.PCC.0000161284.96739.3A, 15982437.
45. Hall NJ, Peters M, Eaton S, Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004, 39:898-901. 10.1016/j.jpedsurg.2004.02.005, 15185221.
46. Halverson-Steele B. The influence of hyperglycaemia on outcome in children following cardiac surgery. (Abstract PCIC Miami Dec 2004). Pediatric Critical Care Medicine 2005,
47. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005, 146:30-4. 10.1016/j.jpeds.2004.08.076, 15644818.
48. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. The Journal of trauma 2005, 59:1148. 10.1097/01.ta.0000188933.16637.68, 16385293.
49. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002, 123:110. 10.1067/mtc.2002.119064, 11782764.
50. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-8. 10.1056/NEJM200005043421801, 10793162, The Acute Respiratory Distress Syndrome Network.
51. Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002, 30:1772-7. 10.1097/00003246-200208000-00016, 12163791.
52. Curley MAQ, JJ Z. Alternative outcome measures for pediatric clinical sepsis trials. Pediatr Crit Care Med 2005, 6(Suppl):150-56. 10.1097/01.PCC.0000161582.63265.B6, 15730600.
53. Leteurtre S, Martinot A, Duhamel A. Development of a pediatric multiple organ dysfunction score: use of two strategies. Med Decis Making 1999, 19:399-410. 10.1177/0272989X9901900408, 10520678.
54. Lacroix J, Cotting J. Severity of illness and organ dysfunction scoring in children. Pediatr Crit Care Med 2005, 6(Suppl):126-34.
55. Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK. Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics 1990, 85:834-7.
56. NHS Information Standards Board. Paediatric Critical Care Minimum Data Set. 2006, , http://www.isb.nhs.uk/docs/paediatric-critical-care-minimum-data-set-1
57. Field D, Elbourne D, Truesdale A, Grieve R, Hardy P, Fenton AC, Subhedar N, Ahluwalia J, Halliday HL, Stocks J, Tomlin K, Normand C, . INNOVO Trial Collaborating Group Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomized controlled trial. Pediatrics 2005, 115:926-36. 10.1542/peds.2004-1209, 15805366, INNOVO Trial Collaborating Group.
58. Payment by Results (PBr), 2008-9. Department of Health., http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081096
59. Curtis L. Unit Costs of Health and Social Care 2007. Canterbury, UK: PSSRU Personal Social Services Research Unit., http://www.pssru.ac.uk/uc/uc2007contents.htm
60. Haybittle JL. Repeated assessment of results in clinical trials of cancer treatment. British Journal of Radiology 1971, 44:793 97.
61. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977, 35:1-39. 2025310, 831755.